Sanofi Accelerates Global Shipping of BEYFORTUS® Ahead of 2025–2026 RSV Season

sanofi

Sanofi made early Q3 global availability of BEYFORTUS® (nirsevimab) to stock up on the healthcare providers ahead of the 2025–2026 respiratory syncytial virus (RSV) season, which generally runs from November through March. Advancements in Immune Thrombocytopenia (ITP) Sanofi shared Phase 3 LUNA [Read More…]